170 related articles for article (PubMed ID: 37171328)
1. p53 and PTEN expression evaluation with molecular evident recent criteria in laryngeal carcinoma.
Tan A; Eskiizmir G; Kamiloglu U; Sarioglu S
Medicine (Baltimore); 2023 May; 102(19):e33676. PubMed ID: 37171328
[TBL] [Abstract][Full Text] [Related]
2. Expression of PTEN protein in patients with laryngeal squamous cell carcinoma.
Guney K; Ozbilim G; Derin AT; Cetin S
Auris Nasus Larynx; 2007 Dec; 34(4):481-6. PubMed ID: 17475427
[TBL] [Abstract][Full Text] [Related]
3. Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer.
Chun SH; Jung CK; Won HS; Kang JH; Kim YS; Kim MS
Head Neck; 2015 May; 37(5):636-43. PubMed ID: 24616007
[TBL] [Abstract][Full Text] [Related]
4. [Expression of p-STAT3 in laryngeal squamous carcinoma and its correlation with PTEN].
Zhao H; Wamg Y; He X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Sep; 27(18):981-5. PubMed ID: 24459921
[TBL] [Abstract][Full Text] [Related]
5. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.
Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS
J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652
[TBL] [Abstract][Full Text] [Related]
6. [Expression of tumor suppressor gene PTEN in laryngeal carcinoma and its clinical significance].
Chen J; Li X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 May; 20(10):454-6. PubMed ID: 16883792
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of p53 and c-erbB-2 oncoproteins in laryngeal carcinoma.
Kazkayasi M; Hücümenoğlu S; Siriner GI; Hücümenoğlu M
Eur Arch Otorhinolaryngol; 2001 Sep; 258(7):329-35. PubMed ID: 11699821
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers.
Lee YK; Park NH
Gynecol Oncol; 2009 Mar; 112(3):475-80. PubMed ID: 19150122
[TBL] [Abstract][Full Text] [Related]
9. PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma.
Liu YY; Yao SN; Zhao Y; Yao ZH; Ma J; Xia QX; Fu K; Yang SJ
Leuk Lymphoma; 2010 Sep; 51(9):1692-8. PubMed ID: 20807096
[TBL] [Abstract][Full Text] [Related]
10. High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function.
Yndestad S; Austreid E; Knappskog S; Chrisanthar R; Lilleng PK; Lønning PE; Eikesdal HP
Breast Cancer Res Treat; 2017 May; 163(1):177-190. PubMed ID: 28213783
[TBL] [Abstract][Full Text] [Related]
11. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of INPP4B protein immunohistochemistry in ovarian cancer.
Salmena L; Shaw P; Fans I; McLaughlin ; Rosen B; Risch H; Mitchell C; Sun P; Narod SA; Kotsopoulos J
Eur J Gynaecol Oncol; 2015; 36(3):260-7. PubMed ID: 26189250
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
Li M; Zhao L; Shen D; Li X; Wang J; Wei L
Chin Med J (Engl); 2014; 127(8):1459-63. PubMed ID: 24762589
[TBL] [Abstract][Full Text] [Related]
14. Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx.
Sullu Y; Gun S; Atmaca S; Karagoz F; Kandemir B
Diagn Pathol; 2010 Jun; 5():35. PubMed ID: 20546613
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis.
Kang HJ; Lee IS; Park YS; Ho WJ; Sohn D; Ahn JY; Yook JH; Kim BS
Ann Surg Oncol; 2016 Oct; 23(11):3684-3692. PubMed ID: 27221363
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance and expression of FLIP and PTEN protein in laryngeal squamous cell carcinoma].
Wei Z; Jiang X; Zhou X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Feb; 21(3):103-6. PubMed ID: 17441421
[TBL] [Abstract][Full Text] [Related]
17. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
Li Q; Zhang B; Peng P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
[TBL] [Abstract][Full Text] [Related]
18. A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy.
Huang X; Zhang Y; Tang Y; Butler N; Kim J; Guessous F; Schiff D; Mandell J; Abounader R
Neoplasia; 2013 Aug; 15(8):952-65. PubMed ID: 23908595
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study.
Daniilidou K; Frangou-Plemenou M; Grammatikakis J; Grigoriou O; Vitoratos N; Kondi-Pafiti A
J BUON; 2013; 18(1):195-201. PubMed ID: 23613406
[TBL] [Abstract][Full Text] [Related]
20. [Correlations of p-AKT with PTEN, P53, HER-2 expressions in endometrial carcinoma and their relationship with patient survival].
Zhang XM; Liang Y; Dong Y; Zhang Y; Wang Y; Meng YT; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 44(1):135-41. PubMed ID: 22353917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
